Mamun Al Mahtab1*, Ahmed Lutful Moben2, Md Abdur Rahim3, Md Ashraful Alam4, Sheikh Mohammad Noor-E-Alam1, Faiz Ahmad Khondaker5, Most Rokshana Begum5, Dulal Chandra Das1, Md Atikul Islam6, Partho Pratik Roy7, Md Zahurul Huq8, Mohammad Helal Uddin9 and Musarrat Mahtab10
1Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
2Department of Medicine, Kurmitola General Hospital, Dhaka, Bangladesh
3Department of Hepatology, Abdul Malek Ukil Medical College, Noakhali, Bangladesh
4Department of Hepatology, Shaheed Tajuddin Ahmed Medical College, Gazipur, Bangladesh
5Department of Hepatology, Shaheed Suhrawardy Medical College, Dhaka, Bangladesh
6Sheikh Russel GastroLiver Institute and Hospital, Dhaka, Bangladesh
7Department of Anatomy, Shaheed Suhrawardy Medical College, Dhaka, Bangladesh
8Department of Anesthesiology, National Institute of Cardiovascular Diseases, Dhaka, Bangladesh
9Forum for the Study of the Liver, Dhaka, Bangladesh
10Department of Biochemistry and Biotechnology, North South University, Dhaka, Bangladesh
*Corresponding Author: Mamun Al Mahtab, Professor, Chairman, Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Received: September 26, 2020; Published: October 17, 2020
Acute and acute-on-chronic liver failure (ACLF) is the consequence of acute insult of the liver on the background of underlying compensated chronic liver disease and may result from a wide variety of causes. The short-term mortality may be as high as 65% at 3 months [1]. This is the result of multi-organ failure involving both liver as well as extra hepatic organs as a consequence of bizarre systemic inflammation [2].
Citation: Mamun Al Mahtab., et al. “Initial Experience of “Mujib Protocol”, Therapeutic Plasma Exchange in Acute on Chronic Liver Failure: A Tribute to Father of the Nation of Bangladesh in his Birth Centennial". Acta Scientific Gastrointestinal Disorders 3.11 (2020): 20-22.
Copyright: © 2020 Mamun Al Mahtab., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
